News
MannKind (MNKD) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
MannKind (NASDAQ: MNKD)Q2 2024 Earnings CallAug 07, 2024, 9:00 a.m. ET
Operator
Source Fool.com
Why Latham Group Stock Is Making a Splash Today
Swimming pool manufacturer Latham Group (NASDAQ: SWIM) rode a wave of cost cuts to better-than-expected earnings. Investors are diving in, sending Latham shares up 42% as of 2:30 p.m. ET.
Latham
Why Amgen Stock Is Down Today Despite Solid Q2 Results
By no means were Amgen's (NASDAQ: AMGN) second-quarter numbers "bad." Revenue for most of its core drugs was up year over year, and the slight earnings dip is the predictable result of rising
Here's My Top AI Stock to Buy in August
Let's be honest. After the stunning launch of OpenAI's ChatGPT in late 2022, the generative artificial intelligence (AI) industry has been more hype than substance. While hardware makers like Nvidia
Humana Foundation Announces 2024 Scholarship Awards
The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 42 years, today announced 80 winners of college scholarships awarded through the Humana Foundation Scholarship
3 Dividend Growth Stocks to Buy Hand Over Fist in August
Dividend growth investing is an excellent strategy for any long-term investor. It involves buying and holding companies that pay and raise their dividends year after year. Investors benefit from
EQS-News: Evotec SE reports first half-year 2024 results on 14 August 2024
Exelixis (EXEL) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Exelixis (NASDAQ: EXEL)Q2 2024 Earnings CallAug 06, 2024, 5:00 p.m. ET
Operator
Source Fool.com
Dynavax Technologies (DVAX) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Dynavax Technologies (NASDAQ: DVAX)Q2 2024 Earnings CallAug 06, 2024, 4:30 p.m. ET
Operator
Source Fool.com
Karyopharm Therapeutics (KPTI) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Karyopharm Therapeutics (NASDAQ: KPTI)Q2 2024 Earnings CallAug 06, 2024, 8:00 a.m. ET
Operator
Source Fool.com
Zoetis (ZTS) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Zoetis (NYSE: ZTS)Q2 2024 Earnings CallAug 06, 2024, 8:00 a.m. ET
Operator
Source Fool.com
Why Zoetis Stock Was Moving Higher Tuesday
Shares of Zoetis (NYSE: ZTS), the leading animal pharmaceutical maker, were climbing today after the company reported better-than-expected results in its second-quarter earnings report and raised
2 Dividend Stocks to Buy and Never Sell
Every corporation will face challenges and setbacks -- which will sometimes sink its stock price. That's not a good reason for long-term investors to jump ship unless, of course, there's a
Down 40% in 1 Day, Is DexCom Stock Still a Buy?
July 25 was a difficult day for DexCom (NASDAQ: DXCM) shareholders, with the company's second-quarter earnings release crashing the stock by 40%. To make matters worse, at the moment it's unclear
3 Unstoppable Dividend Stocks Yielding More Than 4% for Income-Seeking Investors to Buy in August and Hold Forever
The past week has been a rotten one for most portfolios. On Monday, Aug. 5, the benchmark S&P 500 index began the trading session about 3% lower. That led the benchmark index to a loss of about 9.4%
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
Except for the last several days, the past 12 months have been pretty good for stocks across the board and especially successful for Vertex Pharmaceuticals (NASDAQ: VRTX). Shares of the biotech
EQS-News: Biotest increases sales in the first half of 2024 by 35% to Euro 372 million
EQS-News: Carl Zeiss Meditec closes first nine months of 2023/24 with slight decline in revenue
Axsome Therapeutics (AXSM) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Axsome Therapeutics (NASDAQ: AXSM)Q2 2024 Earnings CallAug 05, 2024, 8:00 a.m. ET
Operator
Source Fool.com
Why Axsome Therapeutics Stock Is Sinking Today
Shares of Axsome Therapeutics (NASDAQ: AXSM) were sinking 7.5% as of 11:24 a.m. ET on Monday. And while many stocks were tumbling due to the Bank of Japan's interest rate hike, that wasn't the main
Prediction: These Could Be the Best-Performing Growth Stocks Through 2030
When it comes to investing in the right companies for your portfolio, you need to ensure you select businesses that you understand and have the competitive advantages, financials, and leadership to
EQS-News: MorphoSys Completes Voluntary Delisting from the Frankfurt Stock Exchange and Nasdaq Global Market
3 Reasons AT&T Stock Can Soar Higher This Year
AT&T (NYSE: T) is a good dividend stock thanks to its high yield. At 5.9%, it's more than four times the S&P 500 average of 1.4%. For income investors, it can make an ideal investment for the long